New drug targets for a rare kidney and liver disease -- MEDICA Trade Fair

New drug targets for a rare kidney and liver disease

09/07/2017

Image: Diagram of the research results; Copyright: Osaka University

Jun-Ya Kaimori: "Our results suggest that the disruption of Pkhd1 and FPC is likely to alter the activity of other E3 ligases."